PD-1 Antibody Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer: a Phase II Clinical Study
Latest Information Update: 10 Aug 2023
At a glance
- Drugs Fluorouracil (Primary) ; Oxaliplatin (Primary) ; Paclitaxel (Primary) ; Sintilimab (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Aug 2023 New trial record